Only you can decide whether you should invest in Palantir Technologies (NYSE:PLTR) or not. However, if you don’t have enough portfolio exposure to the artificial intelligence and data-analytics market segments, here’s a simple idea. Our Palantir stock analysis indicates that a small share position could substantially grow in value over the long run.

As we’ll discover, Palantir Technologies is expanding its presence on more than one continent. At the very least, you might conduct your due diligence on Palantir and consider the company’s value proposition for patient investors. PLTR stock gets a “B” grade and is certainly worth a look in 2024.

PLTR Stock and the Healthcare Connection

It’s a misconception that Palantir Technologies only operates in the defense sector. Palantir stock traders should know that the company’s products have a variety of applications, including healthcare.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

For example, Palantir Technologies recently disclosed a collaboration with the University of Colorado Anschutz Medical Campus. Together, they will establish the Center for Linkage and Acquisition of Data as part of a research program for the National Institutes of Health.

Palantir Technologies is partnering with home and alternate site infusion services provider Option Care Health (NASDAQ:OPCH). Specifically, Option Care Health will deploy Palantir’s Artificial Intelligence Platform for use cases such as “nurse scheduling, patient onboarding, purchasing optimization, and supply chain execution.”

Maybe you never imagined that a stake in Palantir stock would also be an investment in the future of healthcare technology. Yet, Palantir is a surprisingly diversified business and that’s a big part of the company’s value proposition.

Palantir Technologies Is a Multinational Company

Palantir Technologies is a significant tech-services provider in the U.S. public sector. The company has a contract with the U.S. Army, for example, that could be worth up to $115.04 million.

Plus, Palantir is working with other tech-focused businesses and the National Science Foundation to launch the National Artificial Intelligence Research Resource pilot program in order to promote AI research and innovation in the U.S. However, Palantir’s public-sector partnerships aren’t limited to U.S. borders.

Reportedly, Palantir Technologies is teaming up with Carahsoft Canada to deploy Palantir’s operating systems across Canada’s public sector. As reported by AIthority, Carahsoft Canada will be the “sole distributor of the Palantir Platform under the Government of Canada’s Software Licensing Supply Arrangement.”